See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: July 28, 2006

Bipolar Disorders Insomnia Depression

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Bipolar Disorders

This clinical research study will evaluate an investigational drug for adults struggling with bipolar disorder and alcohol use. Candidates 21-60 who have bipolar disorder and a recent history of heavy drinking may be eligible. Volunteers should not be pregnant or nursing, currently hospitalized, or require medical detoxification for treatment of alcohol dependence or withdrawal.

Research sites are located throughout the United States.

More information

Please see



People who have trouble falling asleep and staying asleep are wanted for this research study of an investigational medication. Candidates must be 18-80, have at least a 3-month history of trouble falling asleep and maintaining sleep, and be in good general health. The study consists of two daytime office visits and 10 overnight visits over approximately two months. Compensation for time and travel may be provided.

The research site is in New York City.

More information

Please see



This clinical study for depression seeks volunteers with the following symptoms: feeling sad, overwhelmed, irritable, stressed out, or guilty, experiencing a change in appetite or weight without a medical reason, or thinking and moving slower than usual. Volunteers may be included who are at least 18, have been feeling depressed every day for at least four weeks, and are not currently pregnant or nursing.

The research site is in Stanford, Calif.

More information

Please see


Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.